Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy

BACKGROUND: Ovarian cancer is the most lethal gynecological cancer which is characterized by extensive peritoneal implantation metastasis and malignant ascites. Despite advances in diagnosis and treatment in recent years, the five-year survival rate is only 25–30%. Therefore, developing multifunctio...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiuyu, Qiu, Miaojuan, Wang, Tianqi, Li, Binbin, Zhang, Shiqiang, Zhang, Tianzhi, Liu, Peng, Wang, Qiang, Qian, Zhi Rong, Zhu, Chengming, Wu, Meiying, Zhao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864853/
https://www.ncbi.nlm.nih.gov/pubmed/35193583
http://dx.doi.org/10.1186/s12951-022-01300-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864853/
https://www.ncbi.nlm.nih.gov/pubmed/35193583
http://dx.doi.org/10.1186/s12951-022-01300-4

Ejemplares similares